Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartphone apps show promise for schizophrenia symptom management

NCT ID NCT04147897

Symptom relief Sponsor: University of Washington Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two mobile health (mHealth) strategies to help people with schizophrenia manage their symptoms. 299 participants used smartphone tools to track and improve issues like depression, anxiety, and insomnia. The goal was to see if these digital tools could make a real difference in daily life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

299 people

The number who actually took part.

Started

Jun 2020

Finished

Sep 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

All participants need to be receiving clinical care at participating clinics who have partnered with the research team for this study. Inclusion: 1. Chart diagnosis of SSD (i.e., schizophrenia, schizoaffective disorder, schizotypal disorder, delusional disorder, or schizophreniform disorder; 2. 18 years or older; 3. English-speaking; 4. Own a smartphone that can support FOCUS and active data plan. Exclusion: 1. Used FOCUS in the past; 2. Plan to move or discontinue services at participating clinics in the upcoming 6 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Delusional disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

delusional disorder schizoaffective disorder schizophrenia schizophreniform disorder schizotypal personality disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Schizophrenia

Contacts and locations

Locations

  • Cascade Mental Health Care

    Chehalis, Washington, 98532, United States

  • Compass Health

    Everett, Washington, 98201, United States

  • Comprehensive Healthcare

    Yakima, Washington, 98902, United States

  • Frontier Behavioral Health

    Spokane, Washington, 99201, United States

  • NEW Alliance Counseling Services

    Colville, Washington, 99114, United States

  • Peninsula Behavioral Health

    Port Angeles, Washington, 98362, United States

  • Sound Health

    Seattle, Washington, 98125, United States

  • Valley Cities

    Federal Way, Washington, 98003, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.